CeGaT New Products Posted to GenomeWeb: Thermo Fisher, CDI Labs, CeGaT, More Gene Panel Analysis Refines Risky Genes in Neurodevelopmental Disorder Cases Marked by Epilepsy Investigators used gene panel sequence data to look at rare de novo variant frequencies in potential risk genes for neurodevelopmental disorders with epilepsy. HeiScreen Preps Liquid Biopsy Breast Cancer Test for Year-End Launch Premium The company's assay relies on a set of 15 methylation and microRNA markers to determine whether a woman has breast cancer. B. Braun China, CeGaT Collaborating on Clinical Genetic Testing Services in China As part of the collaboration, B. Braun China founded a subsidiary, called B. Braun Precision Medicine Technology (BBPM), that opened in Shanghai in May. Following Clinical Pilot Study, CeGaT Launches Genetic Disease Prevention Panel Premium The German company validated the panel, which focuses on actionable results, in a 300-participant clinical study in collaboration with Robert-Bosch-Hospital in Stuttgart. Jun 20, 2017 German Genetic Dx Firm CeGaT Obtains CLIA Certification Feb 10, 2017 German Government Funds CeGaT Liquid Biopsy Research Jul 6, 2016 German Health Insurance Allows Reimbursement of NGS Tests Up to Limit; Excludes cfDNA Analysis, PGx Premium Apr 28, 2016 German Genetic Testing Firm CeGaT Eyes International Markets, Developing Liquid Biopsy Assays Premium Dec 4, 2015 Practice Sues German Reimbursement Administrator Over Unpaid Sanger Dx Tests Coupled With Free NGS Premium Jun 10, 2015 Ariosa Licenses NIPT Technology to German Startup, Others Following CE Marking of Test Algorithm Premium Jul 3, 2014 German Dx Firm Taps N-of-One to Provide Clinical Interpretation for NGS Testing Premium Jun 18, 2014 Germany's CeGaT, B. Braun Set up US Dx Subsidiary; Courting 'Large' Partner to Market Services Premium Jun 4, 2014 B Braun Medical, CeGaT Launch US Company Offering NGS-based Dx Panels Nov 13, 2013 Providers Revert to Old Techs as German Statutory Health Insurance Halts Reimbursement for NGS Tests Premium Aug 14, 2013 CeGaT Adds Somatic Tumor Analysis, Develops PGx Panel, Adopts Illumina Platforms Premium Nov 16, 2012 CLARITY Results Indicate Consensus on Clinical Bioinformatics Methods with Some Room for Improvement Premium May 2, 2012 Q&A: CeGaT's Saskia Biskup on Building an NGS-Based Clinical Sequencing Lab Premium Feb 1, 2012 B. Braun Takes 20 Percent Stake in German Diagnostics Firm CeGaT Premium Jan 4, 2011 Next-Gen Sequencing Makes Inroads into Clinical Applications in 2010 Premium Oct 26, 2010 Germany's CeGaT Offers Sequencing-Based Dx Tests on SOLiD for Range of Diseases Premium Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.